Cargando…
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
BACKGROUND: Soluble protein and lipid mediators play essential roles in the tumor environment, but their cellular origins, targets, and clinical relevance are only partially known. We have addressed this question for the most abundant cell types in human ovarian carcinoma ascites, namely tumor cells...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877997/ https://www.ncbi.nlm.nih.gov/pubmed/27215396 http://dx.doi.org/10.1186/s13059-016-0956-6 |
_version_ | 1782433495177494528 |
---|---|
author | Reinartz, Silke Finkernagel, Florian Adhikary, Till Rohnalter, Verena Schumann, Tim Schober, Yvonne Nockher, W. Andreas Nist, Andrea Stiewe, Thorsten Jansen, Julia M. Wagner, Uwe Müller-Brüsselbach, Sabine Müller, Rolf |
author_facet | Reinartz, Silke Finkernagel, Florian Adhikary, Till Rohnalter, Verena Schumann, Tim Schober, Yvonne Nockher, W. Andreas Nist, Andrea Stiewe, Thorsten Jansen, Julia M. Wagner, Uwe Müller-Brüsselbach, Sabine Müller, Rolf |
author_sort | Reinartz, Silke |
collection | PubMed |
description | BACKGROUND: Soluble protein and lipid mediators play essential roles in the tumor environment, but their cellular origins, targets, and clinical relevance are only partially known. We have addressed this question for the most abundant cell types in human ovarian carcinoma ascites, namely tumor cells and tumor-associated macrophages. RESULTS: Transcriptome-derived datasets were adjusted for errors caused by contaminating cell types by an algorithm using expression data derived from pure cell types as references. These data were utilized to construct a network of autocrine and paracrine signaling pathways comprising 358 common and 58 patient-specific signaling mediators and their receptors. RNA sequencing based predictions were confirmed for several proteins and lipid mediators. Published expression microarray results for 1018 patients were used to establish clinical correlations for a number of components with distinct cellular origins and target cells. Clear associations with early relapse were found for STAT3-inducing cytokines, specific components of WNT and fibroblast growth factor signaling, ephrin and semaphorin axon guidance molecules, and TGFβ/BMP-triggered pathways. An association with early relapse was also observed for secretory macrophage-derived phospholipase PLA(2)G(7), its product arachidonic acid (AA) and signaling pathways controlled by the AA metabolites PGE(2), PGI(2), and LTB(4). By contrast, the genes encoding norrin and its receptor frizzled 4, both selectively expressed by cancer cells and previously not linked to tumor suppression, show a striking association with a favorable clinical course. CONCLUSIONS: We have established a signaling network operating in the ovarian cancer microenvironment with previously unidentified pathways and have defined clinically relevant components within this network. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-016-0956-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4877997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48779972016-05-25 A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome Reinartz, Silke Finkernagel, Florian Adhikary, Till Rohnalter, Verena Schumann, Tim Schober, Yvonne Nockher, W. Andreas Nist, Andrea Stiewe, Thorsten Jansen, Julia M. Wagner, Uwe Müller-Brüsselbach, Sabine Müller, Rolf Genome Biol Research BACKGROUND: Soluble protein and lipid mediators play essential roles in the tumor environment, but their cellular origins, targets, and clinical relevance are only partially known. We have addressed this question for the most abundant cell types in human ovarian carcinoma ascites, namely tumor cells and tumor-associated macrophages. RESULTS: Transcriptome-derived datasets were adjusted for errors caused by contaminating cell types by an algorithm using expression data derived from pure cell types as references. These data were utilized to construct a network of autocrine and paracrine signaling pathways comprising 358 common and 58 patient-specific signaling mediators and their receptors. RNA sequencing based predictions were confirmed for several proteins and lipid mediators. Published expression microarray results for 1018 patients were used to establish clinical correlations for a number of components with distinct cellular origins and target cells. Clear associations with early relapse were found for STAT3-inducing cytokines, specific components of WNT and fibroblast growth factor signaling, ephrin and semaphorin axon guidance molecules, and TGFβ/BMP-triggered pathways. An association with early relapse was also observed for secretory macrophage-derived phospholipase PLA(2)G(7), its product arachidonic acid (AA) and signaling pathways controlled by the AA metabolites PGE(2), PGI(2), and LTB(4). By contrast, the genes encoding norrin and its receptor frizzled 4, both selectively expressed by cancer cells and previously not linked to tumor suppression, show a striking association with a favorable clinical course. CONCLUSIONS: We have established a signaling network operating in the ovarian cancer microenvironment with previously unidentified pathways and have defined clinically relevant components within this network. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-016-0956-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-23 /pmc/articles/PMC4877997/ /pubmed/27215396 http://dx.doi.org/10.1186/s13059-016-0956-6 Text en © Reinartz et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Reinartz, Silke Finkernagel, Florian Adhikary, Till Rohnalter, Verena Schumann, Tim Schober, Yvonne Nockher, W. Andreas Nist, Andrea Stiewe, Thorsten Jansen, Julia M. Wagner, Uwe Müller-Brüsselbach, Sabine Müller, Rolf A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
title | A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
title_full | A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
title_fullStr | A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
title_full_unstemmed | A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
title_short | A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
title_sort | transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877997/ https://www.ncbi.nlm.nih.gov/pubmed/27215396 http://dx.doi.org/10.1186/s13059-016-0956-6 |
work_keys_str_mv | AT reinartzsilke atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT finkernagelflorian atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT adhikarytill atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT rohnalterverena atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT schumanntim atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT schoberyvonne atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT nockherwandreas atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT nistandrea atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT stiewethorsten atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT jansenjuliam atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT wagneruwe atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT mullerbrusselbachsabine atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT mullerrolf atranscriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT reinartzsilke transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT finkernagelflorian transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT adhikarytill transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT rohnalterverena transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT schumanntim transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT schoberyvonne transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT nockherwandreas transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT nistandrea transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT stiewethorsten transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT jansenjuliam transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT wagneruwe transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT mullerbrusselbachsabine transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome AT mullerrolf transcriptomebasedglobalmapofsignalingpathwaysintheovariancancermicroenvironmentassociatedwithclinicaloutcome |